Stockscreener 앱 받기
116.49
3.81%
4.28
시간 외 거래:
116.49
Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스
Axsome Therapeutics’ Earnings Call Highlights Growth and Challenges - TipRanks
Axsome Therapeutics, Inc. SEC 10-Q Report - TradingView
Voya Investment Management LLC Boosts Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics Inc earnings beat by $0.08, revenue fell short of estimates - Investing.com Nigeria
Narcolepsy Market: Epidemiology, Therapies, Companies, - openPR.com
Axsome Therapeutics Clocks Around 60% Topline Growth In Q1 - Benzinga
Earnings call transcript: Axsome Therapeutics beats EPS forecast in Q1 2025 - Investing.com
Axsome Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Axsome Q1 2025 slides: 62% revenue growth as CNS portfolio expands - Investing.com India
The three-year returns have been enviable for Axsome Therapeutics (NASDAQ:AXSM) shareholders despite underlying losses increasing - Yahoo Finance
Axsome Therapeutics (AXSM) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
Axsome Therapeutics beats Q1 expectations, shares rise By Investing.com - Investing.com India
Axsome Therapeutics, Inc. Q1 Loss Decreases, Beats Estimates - Nasdaq
Axsome Therapeutics Q1 Loss Narrows, Revenue Increases - marketscreener.com
Axsome: Q1 Earnings Snapshot - San Francisco Chronicle
Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Short Interest Update - MarketBeat
Adage Capital Partners GP L.L.C. Has $5.08 Million Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Ally Bridge Group NY LLC Purchases New Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Boxer Capital Management LLC Buys Shares of 470,000 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
PDT Partners LLC Has $355,000 Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
First Trust Advisors LP Buys 11,488 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $193.00 - MarketBeat
Axsome Therapeutics (AXSM) Expected to Announce Earnings on Monday - MarketBeat
Tower Research Capital LLC TRC Buys 3,931 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Tri Locum Partners LP Purchases 158,048 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Envestnet Asset Management Inc. Raises Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Canada Pension Plan Investment Board Makes New $347,000 Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics (AXSM) Supports Mental Health Awareness with - GuruFocus
Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month - The Spec
Where are the Opportunities in (AXSM) - news.stocktradersdaily.com
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of "Buy" from Brokerages - MarketBeat
RBC Capital Boosts Price Target for Axsome Therapeutics (AXSM) | - GuruFocus
Seven Springs Wealth Group LLC Acquires Shares of 4,005 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Deep Dive Into Axsome Therapeutics Stock: Analyst Perspectives (28 Ratings) - Benzinga
Barclays PLC Buys 36,203 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics price target raised to $193 from $190 at RBC Capital - TipRanks
RBC Raises Price Target on Axsome Therapeutics to $193 From $190, Keeps Outperform Rating - marketscreener.com
Hood River Capital Management LLC Buys 19,701 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
UBS Adjusts Axsome Therapeutics Price Target to $143 From $149, Maintains Buy Rating - marketscreener.com
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline - Yahoo Finance
Marshall Wace LLP Takes Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Raymond James Financial Inc. Takes Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Russell Investments Group Ltd. Buys 18,422 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
0.39%
3.66%
자본화:
|
볼륨(24시간):